Lenalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients: Meta-analysis of Efficacy in Pivotal Randomized Controlled Trials

被引：0
|
作者：
Manier, Salomon [1 ]
Robinson, Suzanne [2 ]
Owen, Melody [3 ]
Dhanasiri, Sujith [2 ]
Frederickson, Andrew [3 ]
Jackson, Graham [4 ]
Facon, Thierry [1 ]
机构：
[1] CHU Lille, Dept Haematol, Lille, France
[2] Celgene Corp, Summit, NJ USA
[3] Precis Xtract, Oakland, CA USA
[4] NCCC Freeman Hosp, Clin Haematol, Newcastle Upon Tyne, Tyne & Wear, England
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
meta-analysis; Multiple myeloma;
D O I：
10.1016/j.clml.2019.09.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OAB-012
引用
收藏
页码：E9 / E10
页数：2
相关论文
共 50 条
  • [21] Efficacy of Isatuximab Combination Regimens in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta of Phase III Randomized Controlled Trials
    Aboaid, Hazem
    Srinivasmurthy, Ramaditya
    Jones, Daniel Thomas
    Nguyen, Kevin
    Nanda, Rishi Kumar
    Thein, Kyaw Zin
    Htut, Thura Win
    BLOOD, 2024, 144 : 7036 - 7037
  • [22] Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for newly diagnosed multiple myeloma: A comparative systematic review and meta-analysis
    Costa, Bruno Almeida
    Costa, Thomaz Alexandre
    Saravia, Sara Diaz
    Felix, Nicole
    Tan, Carlyn Rose
    Korde, Neha
    Richter, Joshua
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (06) : 1056 - 1065
  • [23] Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
    Korde, Neha
    Roschewski, Mark
    Zingone, Adriana
    Kwok, Mary
    Manasanch, Elisabet E.
    Bhutani, Manisha
    Tageja, Nishant
    Kazandjian, Dickran
    Mailankody, Sham
    Wu, Peter
    Morrison, Candis
    Costello, Rene
    Zhang, Yong
    Burton, Debra
    Mulquin, Marcia
    Zuchlinski, Diamond
    Lamping, Liz
    Carpenter, Ashley
    Wall, Yvonne
    Carter, George
    Cunningham, Schuyler C.
    Gounden, Verena
    Sissung, Tristan M.
    Peer, Cody
    Maric, Irina
    Calvo, Katherine R.
    Braylan, Raul
    Yuan, Constance
    Stetler-Stevenson, Maryalice
    Arthur, Diane C.
    Kong, Katherine A.
    Weng, Li
    Faham, Malek
    Lindenberg, Liza
    Kurdziel, Karen
    Choyke, Peter
    Steinberg, Seth M.
    Figg, William
    Landgren, Ola
    JAMA ONCOLOGY, 2015, 1 (06) : 746 - 754
  • [24] Efficacy of Induction Thearapy with Lenalidomide, Bortezomib, and Dexamethasone (RVD) in 1000 Newly Diagnosed Multiple Myeloma (MM) Patients
    Joseph, Nisha
    Gupta, Vikas A.
    Hofmeister, Craig C.
    Gleason, Charise
    Heffner, Leonard
    Boise, Lawrence H.
    Kaufman, Jonathan L.
    Dhodapkar, Madhav V.
    Lonial, Sagar
    Nooka, Ajay K.
    BLOOD, 2018, 132
  • [25] Selinexor, Lenalidomide and Dexamethasone (SRd) for Patients with Relapsed/Refractory and Newly Diagnosed Multiple Myeloma
    White, Darrell J.
    LeBlanc, Richard
    Baljevic, Muhamed
    Bahlis, Nizar J.
    Lentzsch, Suzanne
    Venner, Christopher P.
    Gasparetto, Cristina
    Chen, Christine I.
    Lipe, Brea
    Tuchman, Sascha A.
    Sutherland, Heather J.
    Kotb, Rami
    Sebag, Michael
    Callander, Natalie S.
    Bensinger, William I.
    Rossi, Adriana C.
    Sheehan, Heidi
    Van Domelen, Dane
    Zhou, Tianjun
    Kazuharu, Kai
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    Schiller, Gary J.
    BLOOD, 2020, 136
  • [26] Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients
    Gay, Francesca
    Hayman, Suzanne R.
    Lacy, Martha Q.
    Buadi, Francis
    Gertz, Morie A.
    Kumar, Shaji
    Dispenzieri, Angela
    Mikhael, Joseph R.
    Bergsagel, P. Leif
    Dingli, David
    Reeder, Craig B.
    Lust, John A.
    Russell, Stephen J.
    Roy, Vivek
    Zeldenrust, Steven R.
    Witzig, Thomas E.
    Fonseca, Rafael
    Kyle, Robert A.
    Greipp, Philip R.
    Stewart, A. Keith
    Rajkumar, S. Vincent
    BLOOD, 2010, 115 (07) : 1343 - 1350
  • [27] Lenalidomide Compared to Ixazomib Maintenance in Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis
    Lai, Eunice
    Soon, Yu Yang
    Lee, Ainsley Ryan Yan Bin
    Wong, Shi Yin
    Soekojo, Cinnie Yentia
    Ooi, Melissa
    Chng, Wee-Joo
    De Mel, Sanjay
    BLOOD, 2021, 138 : 3776 - +
  • [28] Network Meta-Analysis of Randomized Trials in Relapsed/Refractory Multiple Myeloma: Relative Efficacy for Patients Who Are Lenalidomide-Refractory
    Kastritis, Efstathios
    Harvey, Rebecca
    Cranmer, Holly
    Bianco, Martina
    Fenu, Elisabetta
    La Porte, Charles
    Ramasamy, Karthik
    BLOOD, 2023, 142
  • [29] Immunological Consequences of Lenalidomide with and without Dexamethasone in Newly Diagnosed Multiple Myeloma
    Kloeber, Jake A.
    Kimlinger, Teresa K.
    Haug, Jessica L.
    Henderson, Kimberly J.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    BLOOD, 2019, 134
  • [30] Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma
    Jasielec, Jagoda K.
    Kubicki, Tadeusz
    Raje, Noopur
    Vij, Ravi
    Reece, Donna
    Berdeja, Jesus
    Derman, Benjamin A.
    Rosenbaum, Cara A.
    Richardson, Paul
    Gurbuxani, Sandeep
    Major, Sarah
    Wolfe, Brittany
    Stefka, Andrew T.
    Stephens, Leonor
    Tinari, Kathryn M.
    Hycner, Tyler
    Rojek, Alexandra E.
    Dytfeld, Dominik
    Griffith, Kent A.
    Zimmerman, Todd M.
    Jakubowiak, Andrzej J.
    BLOOD, 2020, 136 (22) : 2513 - 2523
12345